Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs

Detalles Bibliográficos
Autores principales: Stefanizzi, Pasquale, Martinelli, Andrea, Bianchi, Francesco Paolo, Migliore, Giovanni, Tafuri, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Coronavirus – Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553161/
https://www.ncbi.nlm.nih.gov/pubmed/34893012
http://dx.doi.org/10.1080/21645515.2021.2011652
_version_ 1784806405196218368
author Stefanizzi, Pasquale
Martinelli, Andrea
Bianchi, Francesco Paolo
Migliore, Giovanni
Tafuri, Silvio
author_facet Stefanizzi, Pasquale
Martinelli, Andrea
Bianchi, Francesco Paolo
Migliore, Giovanni
Tafuri, Silvio
author_sort Stefanizzi, Pasquale
collection PubMed
description
format Online
Article
Text
id pubmed-9553161
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-95531612022-10-12 Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs Stefanizzi, Pasquale Martinelli, Andrea Bianchi, Francesco Paolo Migliore, Giovanni Tafuri, Silvio Hum Vaccin Immunother Coronavirus – Letters Taylor & Francis 2021-12-10 /pmc/articles/PMC9553161/ /pubmed/34893012 http://dx.doi.org/10.1080/21645515.2021.2011652 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Coronavirus – Letters
Stefanizzi, Pasquale
Martinelli, Andrea
Bianchi, Francesco Paolo
Migliore, Giovanni
Tafuri, Silvio
Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs
title Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs
title_full Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs
title_fullStr Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs
title_full_unstemmed Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs
title_short Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs
title_sort acceptability of the third dose of anti-sars-cov-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of italian hcws
topic Coronavirus – Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553161/
https://www.ncbi.nlm.nih.gov/pubmed/34893012
http://dx.doi.org/10.1080/21645515.2021.2011652
work_keys_str_mv AT stefanizzipasquale acceptabilityofthethirddoseofantisarscov2vaccinecoadministeredwithinfluenzavaccinepreliminarydatainasampleofitalianhcws
AT martinelliandrea acceptabilityofthethirddoseofantisarscov2vaccinecoadministeredwithinfluenzavaccinepreliminarydatainasampleofitalianhcws
AT bianchifrancescopaolo acceptabilityofthethirddoseofantisarscov2vaccinecoadministeredwithinfluenzavaccinepreliminarydatainasampleofitalianhcws
AT miglioregiovanni acceptabilityofthethirddoseofantisarscov2vaccinecoadministeredwithinfluenzavaccinepreliminarydatainasampleofitalianhcws
AT tafurisilvio acceptabilityofthethirddoseofantisarscov2vaccinecoadministeredwithinfluenzavaccinepreliminarydatainasampleofitalianhcws

Ejemplares similares